ZMYND11 and neoplasm: PRMT5 inhibitors are currently being explored as a potential cancer treatment, with various mechanisms proposed to explain their effectiveness.35,37,38,40,79 Our findings indicate that PRMT5 inhibitors can effectively suppress cell growth in ZMYND11-low-expressing cells in vitro and inhibit tumor progression in vivo.